This paper is in the following e-collection/theme issue:

Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1481) JMIR Theme Issue: COVID-19 Special Issue (2388) Outbreak and Pandemic Preparedness and Management (1673) Infectious Diseases (non-STD/STI) (1478) Statistical Methods for Surveillance and Population Health (146) Surveillance Reports (122) Descriptive Epidemiology and Population Size Estimates (85) Innovative Methods in Public Health and Surveillance (305)

Published on in Vol 8, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35763, first published .
Has Omicron Changed the Evolution of the Pandemic?

Has Omicron Changed the Evolution of the Pandemic?

Has Omicron Changed the Evolution of the Pandemic?

Authors of this article:

Alexander L Lundberg1, 2 Author Orcid Image ;   Ramon Lorenzo-Redondo3, 4 Author Orcid Image ;   Egon A Ozer3, 4 Author Orcid Image ;   Claudia A Hawkins3, 5 Author Orcid Image ;   Judd F Hultquist3, 4 Author Orcid Image ;   Sarah B Welch1, 2 Author Orcid Image ;   PV Vara Prasad6 Author Orcid Image ;   James F Oehmke2 Author Orcid Image ;   Chad J Achenbach3, 7 Author Orcid Image ;   Robert L Murphy3, 7 Author Orcid Image ;   Janine I White1 Author Orcid Image ;   Robert J Havey7, 8 Author Orcid Image ;   Lori Ann Post1, 2 Author Orcid Image
Article Authors Cited by (34) Tweetations (4) Metrics

Journals

  1. Patenaude B, Ballreich J. Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19. BMC Public Health 2022;22(1) View
  2. Samara A, Boutlas S, Janho M, Gourgoulianis K, Sotiriou S. COVID-19 Severity and Mortality after Vaccination against SARS-CoV-2 in Central Greece. Journal of Personalized Medicine 2022;12(9):1423 View
  3. Post L, Lorenzo-Redondo R. Omicron: fewer adverse outcomes come with new dangers. The Lancet 2022;399(10332):1280 View
  4. Haschka T, Vergu E, Roche B, Poletto C, Opatowski L. Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant model. BMC Infectious Diseases 2022;22(1) View
  5. De Cos O, Castillo V, Cantarero D. The Role of Functional Urban Areas in the Spread of COVID-19 Omicron (Northern Spain). Journal of Urban Health 2023;100(2):314 View
  6. Palma D, Hernández A, Picchio C, Jodar G, Galbany-Estragués P, Simón P, Guillaumes M, Diez E, Rius C. Confidence in a Vaccine against COVID-19 among Registered Nurses in Barcelona, Spain across Two Time Periods. Vaccines 2022;10(6):873 View
  7. Balde T, Oyugi B, Byakika-Tusiime J, Ogundiran O, Kayita J, Banza F, Landry K, Ejiofor E, Kanyowa T, Mbasha J, Rashidatu K, Atuhebwe P, Gumede N, Herring B, Anoko J, Zongo M, Okeibunor J, O’Malley H, Chamla D, Braka F, Gueye A. Transitioning the COVID-19 response in the WHO African region: a proposed framework for rethinking and rebuilding health systems. BMJ Global Health 2022;7(12):e010242 View
  8. Mullin S, Wyk B, Asher J, Compton S, Allore H, Zeiss C, Nelson K. Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data. PNAS Nexus 2022;1(3) View
  9. Kumar A, Asghar A, Singh H, Faiq M, Kumar S, Narayan R, Kumar G, Dwivedi P, Sahni C, Jha R, Kulandhasamy M, Prasoon P, Sesham K, Kant K, Pandey S. SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis. JMIR Bioinformatics and Biotechnology 2023;4:e42700 View
  10. Lundberg A, Lorenzo-Redondo R, Hultquist J, Hawkins C, Ozer E, Welch S, Prasad P, Achenbach C, White J, Oehmke J, Murphy R, Havey R, Post L. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates. JMIR Public Health and Surveillance 2022;8(6):e37377 View
  11. Ren J, Liu M, Liu Y, Liu J. Optimal resource allocation with spatiotemporal transmission discovery for effective disease control. Infectious Diseases of Poverty 2022;11(1) View
  12. Das S, Samanta S, Banerjee J, Pal A, Giri B, Kar S, Dash S. Is Omicron the end of pandemic or start of a new innings?. Travel Medicine and Infectious Disease 2022;48:102332 View
  13. Melnikova I. Features of clinical manifestations, diagnosis, treatment and prevention of COVID-19 coronavirus infection in children. Russian Family Doctor 2022;26(3):15 View
  14. Sharma S, Agha B, Delgado C, Walson K, Woods C, Gonzalez M, Jerris R, Sysyn G, Beiter J, Kamidani S, Rostad C. Croup Associated With SARS-CoV-2: Pediatric Laryngotracheitis During the Omicron Surge. Journal of the Pediatric Infectious Diseases Society 2022;11(8):371 View
  15. Aljamaan F, Alhaboob A, Saddik B, Bassrawi R, Assiri R, Saeed E, Alhasan K, Alenezi S, Alarabi M, Alrabiaah A, Alkriadees Y, Al-Saud N, Alenazi B, Rabaan A, Halwani R, AlZamil F, Barry M, Memish Z, Al-Tawfiq J, Temsah M. In-Person Schooling Amidst Children’s COVID-19 Vaccination: Exploring Parental Perceptions Just after Omicron Variant Announcement. Vaccines 2022;10(5):768 View
  16. Xu A, Hong B, Lou F, Wang S, Li W, Shafqat A, An X, Zhao Y, Song L, Tong Y, Fan H. Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention. MedComm 2022;3(3) View
  17. Santaniello A, Perruolo G, Cristiano S, Agognon A, Cabaro S, Amato A, Dipineto L, Borrelli L, Formisano P, Fioretti A, Oriente F. SARS-CoV-2 Affects Both Humans and Animals: What Is the Potential Transmission Risk? A Literature Review. Microorganisms 2023;11(2):514 View
  18. Mukerjee N, Maitra S, Das P, Malik S, Alexiou A, Ghosh A. Omicron with threatened antagonistic consequences and are convoyed by new fangled risks – Correspondence. International Journal of Surgery 2022;106:106947 View
  19. Della Polla G, Miraglia del Giudice G, Pelullo C, Angelillo I. Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy. Human Vaccines & Immunotherapeutics 2023;19(1) View
  20. Zhong W, Wu Y, Yue W, Fang J, Xie B, Xu N, Lin M, Zhu X, Su Z, Chen Y, Li H, Li H. Distinguishing COVID-19 from seasonal influenza in patients under age 65 years—a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics. Frontiers in Cellular and Infection Microbiology 2023;13 View
  21. Wang N, Xue J, Xu T, Li H, Liu B. A weapon to fight against pervasive Omicron: systematic actions transiting to pre-COVID normal. Frontiers in Public Health 2023;11 View
  22. Lorenzo-Redondo R, de Sant’Anna Carvalho A, Hultquist J, Ozer E. SARS-CoV-2 genomics and impact on clinical care for COVID-19. Journal of Antimicrobial Chemotherapy 2023;78(Supplement_2):ii25 View
  23. Yin Z, Xiao H, McDonald S, Brusic V, Qiu T. Dynamically adjustable SVEIR(MH) model of multiwave epidemics: Estimating the effects of public health measures against COVID‐19. Journal of Medical Virology 2023;95(12) View
  24. Kawaguchi H, Kakeya H, Nakagami-Yamaguchi E. Assessing the Impact of COVID-19 on Incident Reporting and Elucidating the Characteristics of Incident Reports for COVID-19 Patients at the Critical Care Center of a Tertiary-Care Teaching Hospital in Japan. The Tohoku Journal of Experimental Medicine 2024;262(1):5 View
  25. An G, Mi Z, Hong D, Ou D, Cao X, Liu Q, Xiong L, Li C. Nomogram to predict the incidence of delirium in elderly patients with non-severe SARS-CoV-2 infection. Frontiers in Psychiatry 2024;14 View
  26. Pan Y, Gu M, Mao Q, Ruan X, Du X, Gao X, Chen X, Li A. Clinical Characteristics and High-resolution Computed Tomography Findings of 805 Patients with Mild or Moderate Infection from SARS-CoV-2 Omicron Subvariant BA.2. Current Medical Imaging Reviews 2023;20(1) View
  27. Lundberg A, Wu S, Soetikno A, Hawkins C, Murphy R, Havey R, Ozer E, Moss C, Welch S, Mason M, Liu Y, Post L. Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Europe: Longitudinal Trend Analysis. JMIR Public Health and Surveillance 2024;10:e53551 View
  28. Soetikno A, Lundberg A, Ozer E, Wu S, Welch S, Mason M, Liu Y, Havey R, Murphy R, Hawkins C, Moss C, Post L. Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in the Middle East and North Africa: Longitudinal Trend Analysis. JMIR Public Health and Surveillance 2024;10:e53219 View
  29. Post L, Wu S, Soetikno A, Ozer E, Liu Y, Welch S, Hawkins C, Moss C, Murphy R, Mason M, Havey R, Lundberg A. Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Latin America and the Caribbean: Longitudinal Trend Analysis. JMIR Public Health and Surveillance 2024;10:e44398 View
  30. Lundberg A, Ozer E, Wu S, Soetikno A, Welch S, Liu Y, Havey R, Murphy R, Hawkins C, Mason M, Post L. Central Asian Surveillance Metrics and History of the COVID-19 Pandemic: Longitudinal Analyses (Preprint). JMIR Public Health and Surveillance 2023 View
  31. Xie L, Deng X, Xie X, Hu S. Analysis and prediction of omicron infection cases daily in the United Kingdom in November and December 2021. Biostatistics & Epidemiology 2024;8(1) View
  32. Post L, Soetikno A, Wu S, Hawkins C, Mason M, Ozer E, Murphy R, Welch S, Liu Y, Havey R, Moss C, Achenbach C, Lundberg A. South Asia’s COVID-19 History and Surveillance: Updated Epidemiological Assessment (Preprint). JMIR Public Health and Surveillance 2023 View
  33. Lundberg A, Soetikno A, Wu S, Ozer E, Welch S, Mason M, Murphy R, Hawkins C, Liu Y, Moss C, Havey R, Achenbach C, Post L. Sub-Saharan Africa Surveillance Metrics and History of the COVID-19 Pandemic: Updated Epidemiological Assessment (Preprint). JMIR Public Health and Surveillance 2023 View

Books/Policy Documents

  1. Dutta S, Bandyopadhyay S, Janarthanan M, Bose P. Proceedings of Third International Conference on Advances in Computer Engineering and Communication Systems. View